{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:29:18Z","timestamp":1787898558906,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bmcl.2019.126754","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T02:49:26Z","timestamp":1572230966000},"page":"126754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening"],"prefix":"10.1016","volume":"29","author":[{"given":"Alexander","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.126754_b0005","doi-asserted-by":"crossref","unstructured":"Thies W, Bleiler L. 2012 Alzheimer\u2019s disease facts and figures. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2012.","DOI":"10.1016\/j.jalz.2012.02.001"},{"key":"10.1016\/j.bmcl.2019.126754_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.55782\/ane-2004-1495","article-title":"Alzheimer's disease and acetylcholine receptors","volume":"64","author":"Kihara","year":"2004","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"10.1016\/j.bmcl.2019.126754_b0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/JMN:30:1:219","article-title":"Acetylcholine, cognition, and consciousness","volume":"30","author":"Woolf","year":"2006","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bmcl.2019.126754_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0301-0082(97)00094-4","article-title":"A structural basis for memory storage in mammals","volume":"55","author":"Woolf","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bmcl.2019.126754_b0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002018-199819060-00004","article-title":"Cholinesterase inhibitors in the treatment of Alzheimer\u2019s disease","volume":"19","author":"Nordberg","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.bmcl.2019.126754_b0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cbi.2009.11.018","article-title":"Cholinesterase inhibitors and memory","volume":"187","author":"Pepeu","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2019.126754_b0035","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2019.126754_b0040","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int J Geriatric Psychiatry"},{"key":"10.1016\/j.bmcl.2019.126754_b0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00002512-200118120-00001","article-title":"Selective inhibitors of butyrylcholinesterase","volume":"18","author":"Giacobini","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bmcl.2019.126754_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmcl.2019.126754_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004836-199801000-00015","article-title":"Tacrine: a cause of fatal hepatotoxicity?","volume":"26","author":"Blackard","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bmcl.2019.126754_b0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.bmcl.2019.126754_b0065","doi-asserted-by":"crossref","unstructured":"Mehta M, Adem A, Sabbagh MJIJoAsd. New acetylcholinesterase inhibitors for Alzheimer's disease. 2012;2012.","DOI":"10.1155\/2012\/728983"},{"key":"10.1016\/j.bmcl.2019.126754_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.05.051","article-title":"Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds","author":"Zhou","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2019.126754_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Ko\u0161ak","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejmech.2018.07.033","article-title":"Multi-target-directed ligands for treating Alzheimer's disease: butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities","volume":"156","author":"Knez","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0085","doi-asserted-by":"crossref","first-page":"39495","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2019.126754_b0090","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0095","doi-asserted-by":"crossref","first-page":"16762","DOI":"10.1038\/s41598-018-35196-8","article-title":"Blocking drug activation as a therapeutic strategy to attenuate acute toxicity and physiological effects of heroin","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2019.126754_b0100","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1039\/C3OB42464B","article-title":"Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine","volume":"12","author":"Qiao","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0105","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1021\/bi400709v","article-title":"Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin","volume":"52","author":"Qiao","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2019.126754_b0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(01)00689-X","article-title":"\u03bc Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine","volume":"62","author":"Selley","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2019.126754_b0115","article-title":"Ethopropazine and benztropine in neuroleptic-induced parkinsonism","author":"Chouinard","year":"1979","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bmcl.2019.126754_b0120","article-title":"The Truven health MarketScan databases for life sciences researchers","author":"Hansen","year":"2017","journal-title":"Truven Health Ananlytics IBM Watson Health"},{"key":"10.1016\/j.bmcl.2019.126754_b0125","series-title":"Drug company pleads guilty to deceit in product testing","author":"Hilts","year":"1995"},{"key":"10.1016\/j.bmcl.2019.126754_b0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3565(25)23238-4","article-title":"Comparative inhibitory effects of various physostigmine analogs against acetyl-and butyrylcholinesterases","volume":"249","author":"Atack","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2019.126754_b0135","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bmcl.2019.126754_b0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl-and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2019.126754_b0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0150","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126754_b0155","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2019.126754_b0160","doi-asserted-by":"crossref","first-page":"W442","DOI":"10.1093\/nar\/gkw287","article-title":"Pharmit: interactive exploration of chemical space","volume":"44","author":"Sunseri","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2019.126754_b0165","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1021\/ci300604z","article-title":"Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise","volume":"53","author":"Koes","year":"2013","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2019.126754_b0170","first-page":"798","article-title":"Ellman's method is still an appropriate method for measurement of cholinesterases activities","volume":"17","author":"Shetab-Boushehri","year":"2018","journal-title":"EXCLI J"},{"key":"10.1016\/j.bmcl.2019.126754_b0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2019.126754_b0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","article-title":"Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench","volume":"25","author":"Waterhouse","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:30:42Z","timestamp":1760772642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19307176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0960894X19307176"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126754","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126754"}}